Bio-Works Technologies AB today announced a strategic partnership with Zenmindes Biotechnology Co., Ltd., aimed at establishing a strong and sustainable presence in China's rapidly expanding biopharmaceutical market.
China is one of the world's most dynamic biopharma markets, marked by a growing demand for high-performance chromatography resins. Through this collaboration, Bio-Works takes a significant step forward in meeting that demand with local expertise, dedicated support, and a long-term growth strategy.
"This partnership marks an important milestone in our global expansion journey. By combining Swedish innovation with local market insight, we can build stronger customer relationships and accelerate our growth across Asia," said Lone Carlbom, CEO of Bio-Works Technologies AB.
A partnership built on shared growth and investment
The collaboration with Zenmindes extends beyond traditional distribution and includes:
Together, Bio-Works and Zenmindes are laying the foundation for sustainable, measurable growth-driven by shared investments, combined expertise, and long-term commitment.